AudioEye expects over $15M run rate adjusted EBITDA by end of 2026 as it raises full-year adjusted EBITDA guidance to at least $12.7M

Daré Bioscience targets Ovaprene top-line data in 2027 as it plans DARE to PLAY dispensing this quarter

2026/08/14

Why Coherent Stock Jumped Before Its Own Results Landed

2026/08/14

Jefferson Capital outlines $1.1B expected ERC collections in next 12 months while entering Mexico market

2026/08/14

FocalTherics reiterates $50M-$54M 2026 HIFU revenue outlook as it closes $40M equity offering

2026/08/14